Alvotech

US$4.86As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ALVOHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (11.29%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.24
PE TTM —
TSR TTM (36.47%)
Mkt cap US$1.735B
ROIC 4.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.69
16.99%
(18.82%)
Hold 8|3|1|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
6.46%
7.30%
8.87%
8.09%
Revenue$M
168.4
175.7
182.8
188.4
13.56%
19.43%
21.58%
18.35%
Peers (US$1.735B)
Cap (US$)
PE
17.00B
34.65x
346.4M
73.06x
1.722B
189.9x
1.713B
90.31x
Capital
TTM
5Y
10Y
Leveragex
2.678
1.120
0.956
EBIT/Intx
0.075
0.728
0.648
Own earn%
(106.34)
49.94
40.01
Sh yield%
17.00
60.10
51.55
Owners
Insiders/Inst%
8.45
70.96
Short interest%
4.85
SBC / revenue%
5.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
3–15
$1 testx
—
Incr. ROIC%
1